Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. (QNRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · QNRX · as of Jun 9, 2026
Key Statistics
Explore Quoin Pharmaceuticals, Ltd. Data
qnrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
qnrx competitorsQNRX
CYCN
KTTA
NBY
PLRZ
PMCBStock Performance
Full HistoryAbout Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QR…
what is quoin pharmaceuticals, ltd. · qnrx stock overview · quoin pharmaceuticals, ltd. company profile · who is quoin pharmaceuticals, ltd. ceo · qnrx NASDAQ · quoin pharmaceuticals, ltd. headquarters · quoin pharmaceuticals, ltd. business segments
About Stock Overview & Key Data
Quoin Pharmaceuticals, Ltd. (QNRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 1, 2016. As of the latest trading session, QNRX stock price is $4.57, with a market capitalization of $2.7M. The stock has returned -46.36% over the past 12 months and -68.33% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Quoin Pharmaceuticals, Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Quoin Pharmaceuticals, Ltd. reported revenue of — and net income of -$15.8M. For detailed data — including Quoin Pharmaceuticals, Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Quoin Pharmaceuticals, Ltd. (QNRX) stock price is $4.57. The stock is traded on NASDAQ under the ticker symbol QNRX. The 52-week range is $4.11 – $41.80.